中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden

文献类型:期刊论文

作者Hong, Xiaohua2; Shen, Aijun1; Xu, Yu3; Li, Chengcheng3; Wang, Guoqiang3; Liu, Li2; Qi, Chuang3
刊名CANCER RESEARCH
出版日期2019-07-01
卷号79期号:13页码:2
ISSN号0008-5472
DOI10.1158/1538-7445.AM2019-4011
WOS研究方向Oncology
语种英语
WOS记录号WOS:000488279403408
出版者AMER ASSOC CANCER RESEARCH
源URL[http://119.78.100.183/handle/2S10ELR8/282682]  
专题新药研究国家重点实验室
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai, Peoples R China
2.Huazhong Univ Sci & Technol, Coll Med, Union Hosp, Ctr Canc, Wuhan, Hubei, Peoples R China
3.3D Med Inc, Dept Med, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Hong, Xiaohua,Shen, Aijun,Xu, Yu,et al. Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden[J]. CANCER RESEARCH,2019,79(13):2.
APA Hong, Xiaohua.,Shen, Aijun.,Xu, Yu.,Li, Chengcheng.,Wang, Guoqiang.,...&Qi, Chuang.(2019).Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden.CANCER RESEARCH,79(13),2.
MLA Hong, Xiaohua,et al."Notch 1/2/3 mutation as a potential biomarker for immunotherapy in smokers with non-small cell lung cancer via increasing tumor mutational burden".CANCER RESEARCH 79.13(2019):2.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。